Michael Gelband’s Oscar Health OSCR Stock Holding History

Michael Gelband’s Portfolio OSCR Stock Details OSCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.76M	Sell	61,869 -103,664	-63%	-$2.23M	0.01%	869
2026 Q1	$1.9M	Sell	165,533 -178,038	-52%	-$2.51M	0.02%	804
2025 Q4	$4.94M	Buy	343,571 +201,211	+141%	+$3.48M	0.04%	472
2025 Q3	$2.69M	Buy	142,360 +132,077	+1,284%	+$2.18M	0.03%	629
2025 Q2	$220K	Sell	10,283 -171,861	-94%	-$2.55M	﹤0.01%	1299
2025 Q1	$2.39M	Sell	182,144 -8,006	-4%	-$119K	0.02%	645
2024 Q4	$2.56M	Buy	+190,150	New	+$3.06M	0.02%	636
2023 Q3	–	Sell	-12,097	Closed	-$98K	–	2017
2023 Q2	$98K	Buy	+12,097	New	+$89.2K	﹤0.01%	1754
2023 Q1	–	Sell	-211,658	Closed	-$521K	–	2035
2022 Q4	$521K	Sell	211,658 -75,523	-26%	-$236K	0.01%	1159
2022 Q3	$1.43M	Buy	287,181 +26,986	+10%	+$158K	0.02%	952
2022 Q2	$1.11M	Sell	260,195 -100,448	-28%	-$639K	0.01%	1035
2022 Q1	$3.6M	Buy	360,643 +303,595	+532%	+$2.26M	0.05%	508
2021 Q4	$448K	Buy	57,048 +33,761	+145%	+$424K	﹤0.01%	1476
2021 Q3	$405K	Buy	+23,287	New	+$395K	0.01%	1498

Other funds holding OSCR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

TCMNY

Thrive Capital Management (New York) New York $3.81B AUM 45.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Michael Gelband's OSCR Position: Q2 2026 in Review

Michael Gelband reduced its Oscar Health (OSCR) stake by 63% in Q2 2026, selling an estimated $2.23M and leaving 61,869 shares worth $1.76M. The position accounts for 0.01% of the portfolio, ranked #869.

Michael Gelband first reported a position in OSCR in Q3 2021 and has held it in 14 quarters since. The position peaked at $4.94M in Q4 2025. 401 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

Michael Gelband held 61,869 shares of Oscar Health worth $1.76M as of Q2 2026.
Michael Gelband sold 103,664 Oscar Health shares in Q2 2026, an estimated $2.23M.
Oscar Health made up 0.01% of Michael Gelband's portfolio in Q2 2026, its #869 holding.
Michael Gelband first reported a position in Oscar Health in Q3 2021 and has held it in 14 quarters since.
Michael Gelband's Oscar Health position peaked at $4.94M in Q4 2025.
401 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.